Multifunctionality and Possible Medical Application of the BPC 157 PeptideLiterature and Patent Review RFK Jr. promotes peptides. Now the FDA weighs easing limits on the unproven chemicals The Hidden Risks of BPC157: What Patients Need to Know About Contamination and Safety Regenexx at New Regeneration Orthopedics The biggest peptide story of 2026 may not be a new study. It may be the FDA review calendar. BPC 157, TB 500, MOTS c, Semax, and other peptides are headed into FDA advisory review Multifunctionality and Possible Medical Application of the BPC 157 PeptideLiterature and Patent Review FDA moves toward easing restrictions on certain peptides BioPharma Dive